Mounjaro's sales dip: How cheap generics are redrawing India's GLP-1 market The arrival of cheaper semaglutide alternatives signals that the Indian obesity drug market has moved from a launch-led boom into something more structurally competitive Eli Lilly's Mounjaro posted its first monthly sales drop in India in Marcha Rs 20-crore decline, from roughly Rs 135 crore in February to Rs 114 crorejust days after a clutch of Indian generics entered the country's booming GLP-1 market
Down syndrome Down syndrome is due to trisomy 21, the most common chromosomal abnormality occurring in humans
Blood tests usually confirm low vitamin B12 levels before injections are started
Yacon syrup: Yacon syrup is high in prebiotics, such as FOS, so it may support gut health and healthy blood sugar levels
However, many doctors do not view glutathione as a "foreign" substance in the same way they might view a synthetic drug
If you are a 503A and are approached about acquiring GLP-1 drugs prepared by a 503B for dispensing to patients pursuant to a prescription and are considering doing so we urge you to consult your attorney for advice.